HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Restenosis after endovascular PTA/stenting for supra-aortic branches in Takayasu aortitis: report of three cases and review of the literature.

Abstract
Recently, endovascular management has been reported as a feasible option for Takayasu aortitis. However, few papers have focused on restenosis in the follow-up, and therefore, it is important to predict high-risk cases for restenosis after endovascular treatment. We herein report three cases with Takayasu aortitis showing repeated restenosis after endovascular percutaneous transluminal angioplasty (PTA)/stenting and discuss its clinical implications with a review of the literature. We should keep in mind that endovascular PTA/stenting for Takayasu aortitis does not always keep the patency of the affected vessels, and severity of the stenosis and/or uncontrollable systemic inflammation could be a risk factor for restenosis. Therefore, careful follow-up under strict control of inflammation is mandatory. Overall, this method is effective as an initial treatment since repeated PTA is available until collateral supply develops.
AuthorsNobutaka Horie, Kentaro Hayashi, Minoru Morikawa, Gohei So, Hideaki Takahata, Kazuhiko Suyama, Izumi Nagata
JournalActa neurochirurgica (Acta Neurochir (Wien)) Vol. 153 Issue 5 Pg. 1135-9; discussion 1139 (May 2011) ISSN: 0942-0940 [Electronic] Austria
PMID21336809 (Publication Type: Case Reports, Journal Article, Review)
Topics
  • Adult
  • Angioplasty (instrumentation, methods)
  • Carotid Artery, Common (diagnostic imaging, pathology)
  • Female
  • Graft Occlusion, Vascular (diagnostic imaging, pathology)
  • Humans
  • Radiography
  • Secondary Prevention
  • Stents (standards)
  • Subclavian Artery (diagnostic imaging, pathology)
  • Takayasu Arteritis (complications, drug therapy, pathology)
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: